Smartleaf Asset Management’s Integra LifeSciences IART Stock Holding History

Smartleaf Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.32K	Buy	+79	New	+$1.36K	﹤0.01%	3130
2026 Q1	–	Sell	-14	Closed	-$178	–	3589
2025 Q4	$178	Buy	+14	New	+$186	﹤0.01%	3373
2025 Q2	–	Sell	-11	Closed	-$238	–	2839
2025 Q1	$238	Sell	11 -6	-35%	-$141	﹤0.01%	2775
2024 Q4	$381	Sell	17 -69	-80%	-$1.51K	﹤0.01%	2815
2024 Q3	$1.54K	Sell	86 -2,802	-97%	-$64.9K	﹤0.01%	2560
2024 Q2	$83K	Sell	2,888 -88	-3%	-$2.61K	0.01%	628
2024 Q1	$104K	Buy	2,976 +87	+3%	+$3.48K	0.02%	507
2023 Q4	$127K	Buy	+2,889	New	+$114K	0.03%	388

Other funds holding IART

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Paradigm Capital Management Inc Albany, New York $3.17B AUM 63.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $33.9B AUM 47.7% 1-Year Est. Return

Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return

Smartleaf Asset Management's IART Position: Q3 2026 in Review

Smartleaf Asset Management opened a new position in Integra LifeSciences (IART) in Q3 2026: 79 shares worth $1.32K. The stake represents ﹤0.01% of the portfolio and ranks #3130 among its holdings. This is a return to the name: Smartleaf Asset Management previously reported a position in IART as recently as Q4 2025.

Smartleaf Asset Management first reported a position in IART in Q4 2023 and has held it in 8 quarters since. The position peaked at $127K in Q4 2023. 179 funds tracked by Wall St. Rank hold IART as of Q3 2026.

Smartleaf Asset Management held 79 shares of Integra LifeSciences worth $1.32K as of Q3 2026.
Integra LifeSciences was a new Smartleaf Asset Management position in Q3 2026.
Integra LifeSciences made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #3130 holding.
Smartleaf Asset Management first reported a position in Integra LifeSciences in Q4 2023 and has held it in 8 quarters since.
Smartleaf Asset Management's Integra LifeSciences position peaked at $127K in Q4 2023.
179 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.